619 related articles for article (PubMed ID: 26973101)
1. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
[TBL] [Abstract][Full Text] [Related]
2. GH deficiency confers protective advantages against Alzheimer's disease through rescued miRNA expression profile in APP/PS1 mice.
Noureddine S; Saccon T; Rudeski-Rohr T; Gesing A; Mason JB; Schneider A; Dhabhi J; Puig KL; Rakoczy S; Brown-Borg HM; Masternak MM
Geroscience; 2022 Dec; 44(6):2885-2893. PubMed ID: 35900661
[TBL] [Abstract][Full Text] [Related]
3. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
4. Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice.
Sahu B; Mackos AR; Floden AM; Wold LE; Combs CK
J Alzheimers Dis; 2021; 80(2):761-774. PubMed ID: 33554902
[TBL] [Abstract][Full Text] [Related]
5. Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer's Disease.
Manocha G; Ghatak A; Puig K; Combs C
Curr Alzheimer Res; 2018; 15(12):1123-1135. PubMed ID: 30068274
[TBL] [Abstract][Full Text] [Related]
6. NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.
Manocha GD; Ghatak A; Puig KL; Kraner SD; Norris CM; Combs CK
J Alzheimers Dis; 2017; 58(3):775-787. PubMed ID: 28505967
[TBL] [Abstract][Full Text] [Related]
7. Ca
Yu Z; Dou F; Wang Y; Hou L; Chen H
J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
[TBL] [Abstract][Full Text] [Related]
8. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
[TBL] [Abstract][Full Text] [Related]
9. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
[TBL] [Abstract][Full Text] [Related]
10. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
[TBL] [Abstract][Full Text] [Related]
11. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
[TBL] [Abstract][Full Text] [Related]
17. Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse.
Plucińska K; Crouch B; Yeap JM; Stoppelkamp S; Riedel G; Platt B
J Alzheimers Dis; 2018; 65(1):165-180. PubMed ID: 30040726
[TBL] [Abstract][Full Text] [Related]
18. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
[TBL] [Abstract][Full Text] [Related]
20. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
